Businco Cancer Hospital

Cagliari 09121

0 studies enrolling now · 1 studies all time

What they study most

Smoldering Multiple Myeloma

Studies at this site

• A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma — Completed